Original article
Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia
Aline do Nascimentoa,b,
, Daniel da Silva Pereira Curadoa,b, Thais Montezumaa,c, Wallace Breno Barbosaa,b, Juliana Machado-Rugoloa,d,e, Mariana Millan Fachia,b
Autor para correspondência
anasci.mail@gmail.com
Corresponding author at: Esplanada dos Ministérios bloco G, 8° andar, CEP: 70.058900, Brasília, DF, Brazil.
Corresponding author at: Esplanada dos Ministérios bloco G, 8° andar, CEP: 70.058900, Brasília, DF, Brazil.
